Sixty-nine mutations were detected in CRC002.1-CTC1, including the two predominant tissue mutations in APC and TP53. Nine of 67 (13%) CTC mutations were also found at subthreshold AF in the tumor tissue. This evidence concerns the gene TP53 and neoplasm.